Related Experiment Video
Updated: Aug 12, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
The child with a non-blanching rash: how likely is meningococcal disease?
L C Wells1, J C Smith, V C Weston
1Academic Division of Child Health, Queens Medical Centre, Nottingham NG7 2UH, UK.
Insights
Clinical signs like fever, purpura, and delayed capillary refill can help predict meningococcal infection in children with non-blanching rashes. Early hospital admission and treatment are crucial for ill children.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Diagnostics
Background:
- Meningococcal infection presents a significant health risk in children, often characterized by a non-blanching rash.
- Accurate and timely diagnosis is critical for effective management and improved patient outcomes.
Purpose of the Study:
- To identify simple clinical features and investigations that effectively predict meningococcal infection in children presenting with a non-blanching rash.
- To differentiate between meningococcal and non-meningococcal causes of non-blanching rashes in pediatric patients.
Main Methods:
- A prospective study of 233 infants and children up to 15 years with non-blanching rashes over 12 months.
- Recording and analysis of clinical features and laboratory investigations at presentation.
- Assessment of the predictive value of each feature for meningococcal infection.
Main Results:
- Eleven percent of children had confirmed meningococcal infection.
- Illness, fever (>38.5°C), purpura, and delayed capillary refill (>2 seconds) were more common in meningococcal cases.
- C-reactive protein < 6 mg/l ruled out meningococcal infection; rash distribution to the superior vena cava also indicated a low risk.
Conclusions:
- Children with meningococcal infection typically present with severe illness, purpuric rash, fever, and delayed capillary refill, necessitating urgent hospital admission and treatment.
- A rash confined to the superior vena cava distribution suggests a low likelihood of meningococcal infection.
- C-reactive protein measurement is a potentially useful diagnostic aid; absence of fever does not exclude meningococcal disease.
Aims:
To examine a number of simple clinical features and investigations in children with a non-blanching rash to see which predict meningococcal infection.
Methods:
A total of 233 infants and children up to 15 years of age presenting with a non-blanching rash were studied over a period of 12 months. Clinical features and laboratory investigations were recorded at presentation. The ability of each to predict meningococcal infection was examined.
Results:
Eleven per cent had proven meningococcal infection. Children with meningococcal infection were more likely to be ill, pyrexial (>38.5 degrees C), have purpura, and a capillary refill time of more than two seconds than non-meningococcal children. Five children with meningococcal disease had an axillary temperature below 37.5 degrees C. No child with a rash confined to the distribution of the superior vena cava had meningococcal infection. Investigations were less helpful, although children with meningococcal infection were more likely to have an abnormal neutrophil count and a prolonged international normalised ratio. No child with a C reactive protein of less than 6 mg/l had meningococcal infection.
Conclusions:
Most children with meningococcal infection are ill, have a purpuric rash, a fever, and delayed capillary refill. They should be admitted to hospital and treated without delay. Children with a non-blanching rash confined to the distribution of the superior vena cava are very unlikely to have meningococcal infection. Measurement of C reactive protein may be helpful-no child with a normal value had meningococcal infection. Lack of fever at the time of assessment does not exclude meningococcal disease.
Related Concept Videos
Rocky Mountain Spotted Fever
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

